Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › [6R]—MTHF—an efficient folate alternative in 5-fluorouracil based chemotherapy

[6R]—MTHF—an efficient folate alternative in 5-fluorouracil based chemotherapy

US Patent 11013744 · Granted May 25, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2022
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2022
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2020
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2020
[6R]-MTHF multiple bolus administration in 5-fluorouracil based chemotherapy2019
[6R]-MTHF multiple bolus administration in 5-fluorouracil based chemotherapy2019
[6R]-MTHF multiple bolus administration in 5-fluorouracil based chemotherapy2019
[6R]-MTHF multiple bolus administration in 5-fluorouracil based chemotherapy2019
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2019
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2019
Tetrahydrofolates in combination with EGFR-inhibitors2017
Reduction of toxicity of multi-targeting antifolates2017